Gestational Trophoblastic Disease (GTD) & Molar Pregnancy Treatment in Kolkata
A molar pregnancy or GTD diagnosis can feel overwhelming, especially alongside the emotional weight of a pregnancy that hasn't gone as expected. The most important thing to know is that GTD is one of the most highly treatable and curable conditions in gynaecological oncology — and Dr. Dipanwita Banerjee manages it with the precise hormone tracking and evidence-based protocols it requires.
Whatever stage you are at — early warning signs, a confirmed molar pregnancy, persistently rising β-hCG levels, or planning a future pregnancy after treatment — find your situation below to see how Dr. Banerjee approaches it.
Understanding GTD & molar pregnancy
During a normal pregnancy, cells called trophoblasts form the placenta, which nourishes the developing baby. In Gestational Trophoblastic Disease (GTD), an abnormality during fertilisation causes these cells to grow abnormally inside the uterus — ranging from benign forms, such as a complete or partial hydatidiform mole ("molar pregnancy"), to malignant forms known as Gestational Trophoblastic Neoplasia (GTN), which include invasive moles and choriocarcinoma.
GTD has one of the most reliable tumour markers in modern medicine — human chorionic gonadotropin (β-hCG) — which allows precise diagnosis, monitoring and confirmation of cure. Managing it well requires familiarity with FIGO/WHO risk scoring and serial β-hCG protocols, and Dr. Banerjee's practice covers the complete pathway: diagnosis, evacuation, surveillance, and chemotherapy-based treatment where GTN develops.
GTD & molar pregnancy care, stage by stage
GTD is unusual among gynaecological conditions in that it is tracked almost entirely through a single reliable blood marker — β-hCG. Dr. Banerjee's approach follows the disease's own natural stages closely, from the first suspicious symptoms through to confirmation of cure and future pregnancy planning.
Diagnosis & Confirmation
A molar pregnancy can feel like a normal pregnancy at first. As abnormal tissue grows, warning signs — dark brown or bright red bleeding, unusually severe nausea, or a uterus growing faster than expected — call for prompt, precise diagnosis.
Pelvic Ultrasound
A routine transvaginal ultrasound often reveals the classic "snowstorm" appearance characteristic of a molar pregnancy.
Quantitative Serial β-hCG Testing
Measuring the exact level of β-hCG in the blood — in GTD, levels are typically far higher than in a normal pregnancy, and the trend over time is diagnostic.
Histopathology
Tissue removed during treatment is examined under a microscope to confirm the exact type of molar pregnancy or tumour.
Management of Molar Pregnancy
Most molar pregnancies are managed with a single minor procedure, followed by a defined period of hormone-level surveillance to confirm the disease has fully cleared.
Suction Evacuation (D&C)
Under guidance, the abnormal tissue is carefully removed from the uterus while preserving the uterine lining wherever possible.
Post-Treatment β-hCG Surveillance
Weekly β-hCG blood monitoring is critical until levels drop to zero, followed by monthly checks for several months, to ensure no hidden abnormal cells remain.
Contraception During Surveillance
Reliable contraception is recommended throughout the surveillance period, since a new pregnancy would interfere with β-hCG tracking.
Treatment of Malignant GTN
A plateau or rise in β-hCG after evacuation indicates persistent disease — GTN. It is evaluated using the FIGO/WHO Risk Scoring System and treated according to that risk category.
Low-Risk GTN
Typically treated with single-agent chemotherapy (such as Methotrexate or Actinomycin-D), yielding cure rates near 100%.
High-Risk GTN
Managed with combination chemotherapy regimens and coordinated specialist care to achieve remission.
Surgery (Hysterectomy)
May be considered in select cases — for women who have completed childbearing, or for localised chemo-resistant lesions.
Fertility & Long-Term Follow-Up
One of the most common concerns is whether future pregnancy is still possible. For the vast majority of women treated for GTD or GTN, the answer is yes.
Fertility After Treatment
Treatment for GTD — including single-agent chemotherapy for GTN — does not typically impact long-term fertility or increase the risk of future birth defects.
Planning a Future Pregnancy
Once the recommended surveillance period is complete and cleared by a gynaecological oncologist, patients can safely plan for future pregnancies.
Ongoing Specialist Oversight
Continued monitoring under a gynaecological oncologist ensures treatment has followed international evidence-based guidelines for the best possible outcome.
When to see a specialist sooner
In the early stages, a molar pregnancy may feel like a normal pregnancy. As abnormal tissue grows, certain warning signs may appear:
- Abnormal vaginal bleeding — dark brown or bright red bleeding during the first trimester, the most common sign.
- Severe nausea and vomiting — caused by unusually high levels of β-hCG.
- Rapid uterine growth — the uterus may grow larger and faster than expected for the gestational age.
- Passing grape-like cysts — small fluid-filled sacs passing from the vagina.
- Pelvic pressure or pain — discomfort or a feeling of fullness in the lower abdomen.
- Early high blood pressure (pre-eclampsia) — developing before 20 weeks of pregnancy.
If you experience unusual bleeding or severe symptoms during early pregnancy, it is essential to consult a specialist promptly.
Been told you need treatment for GTD and molar pregnancy, and want it explained in plain words rather than clinical terms? The Patient Guide covers what to expect before, during and after treatment, and in the years afterward.
GTD & Molar Pregnancy, answered directly
What is Gestational Trophoblastic Disease (GTD)?
What are the early warning signs of a molar pregnancy?
How is GTD diagnosed and monitored?
What is Gestational Trophoblastic Neoplasia (GTN) and how is it treated?
Will I be able to have children after treatment for GTD or GTN?
What patients say
I recently visited the Chittaranjan National Cancer Institute (CNCI), Newtown campus, for treatment under Dr. Dipanwita Banerjee (Specialist Gynaecological Oncologist). I cannot praise Dr. Banerjee and her entire team enough. The medical care, surgical expertise, and level of compassion I experienced at this state-of-the-art facility were truly outstanding.
Best Doctor I have ever seen. She is the angel for me… Saved my mother life and my trust… I am thankful to her as well CNCI Hospital where my mother treated very well.
Related Reading
Your care journey, step by step
Discuss your GTD or molar pregnancy concern
"Committed to bringing the highest standard of gynaecological cancer care — with science, skill, and deep compassion — to every patient who trusts me with their care."